Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Director of the Catheterisation Laboratory
Dr José P Henriques is Director of the Catheterisation Laboratory at the Academic Medical Centre of the University of Amsterdam. He also leads the Academic Medical Centre Mechanical support for Acute Congestive Heart failure in ST elevation myocardial infarction (STEMI) patients (AMC MACH) programme. Dr Henriques gained his MD from the University of Amsterdam and his PhD in medicine from the… View more
Author(s): Derek P Chew , Harvey D White Added: 3 years ago
Effective translation of reperfusion therapy to mortality reductions in ST-segment elevation myocardial infarction (STEMI) remains both time-critical in its implementation and dependent on optimal antithrombotic therapy. Innumerable clinical studies have explored several antithrombin and antiplatelet therapies in the immediate management of STEMI. With the wide array of the therapies now… View more
Author(s): Steve Attanasio , Raed Al Dallow , Sandeep Nathan Added: 3 years ago
While acute coronary syndromes inclusive of ST-elevation myocardial infarction (STEMI) have been described in patients with polycythemia vera (PCV), optimal pharmacologic and interventional management strategies in the setting of drastically elevated platelet counts remain unclear.1 To our knowledge this is the first reported case of STEMI with massive thrombus burden in a patient with PCV… View more
Author(s): Robert F Riley , James M McCabe Added: 3 years ago
Heart disease remains the leading cause of death in the US, with ischemic heart disease comprising almost half of these deaths based on the most recent 2013 mortality data.1 While there have been reports of declining rates of acute myocardial infarction (AMI) from various registries and Medicare beneficiary reports, coronary heart disease remained the underlying cause of death in one out of seven… View more
Author(s): Otavio Berwanger , Prof José C Nicolau Added: 6 years ago
Explore the safety and efficacy of ticagrelor compared with clopidogrel in patients with acute coronary syndrome with ST elevation treated with thrombolysis - ACC 2018 An expert peer-to-peer discussion on the latest data to come out of the TREAT trial and its implications for clinical practice. Sunday 11th March 2018 @ 15:00 EST ACC.18 Congress, Orlando, FL Discussants: Dr Otavio Berwanger … View more
Job title: Professor of Interventional Cardiology
Prof Vijay Kunadian is Personal Chair and Professor of Interventional Cardiology at Newcastle University. Prof Kunadian completed all her cardiology training in the North East of England. She undertook an international academic fellowship in cardiology at the TIMI/PERFUSE Study group, Brigham and Women’s Hospital/Harvard Medical School, Boston MA. Prof Kunadian has an international… View more
Author(s): Barbara Stähli Added: 7 months ago
ESC 2023 — Prof Barbara Stähli (University Hospital Zurich, CH) joins us onsite at ESC 23 to outline the findings of the MULTISTARS AMI Trial (NCT03135275). MULTISTARS AMI aimed to compare the safety and efficacy of two treatment strategies currently performed in clinical practice, immediate complete revascularization versus staged complete revascularization in patients presenting with ST… View more
Job title: Professor and Honorary Consultant in Cardiology
Prof Robert Storey is Academic Director and an honorary Consultant Cardiologist for the Cardiology and Cardiothoracic Surgery Directorate, Sheffield Teaching Hospitals NHS Foundation Trust. He is Professor of Cardiology at the University of Sheffield, UK, where he has headed a platelet research group since 2002 within the Department of Cardiovascular Science. He has a special interest in the… View more
Author(s): Felix Böhm Added: 1 week ago
ACC.24 — Investigator, Dr Felix Böhm (Danderyd Hospital, SE) joins us to discuss the findings from a study investigating fractional flow reserve-guided complete or culprit-only percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (MI).1542 patients were enrolled in the trial, who were randomized 1:1 to receive either FFR-guided PCI of non-culprit lesions… View more